Switch to:
Abbott Laboratories (NYSE:ABT)
Research and Development
$1,452 Mil (TTM As of Dec. 2013)

This is the expense the company spent on research and development. Abbott Laboratories's research and development for the three months ended in Dec. 2013 was $386 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2013 was $1,452 Mil.


Definition

This is the expense the company spent on research and development.

Abbott Laboratories Research & Development for the trailing twelve months (TTM) ended in Dec. 2013 was 346.323 (Mar. 2013 ) + 362.557 (Jun. 2013 ) + 356.877 (Sep. 2013 ) + 386.243 (Dec. 2013 ) = $1,452 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Abbott Laboratories Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Research & Development 1,6971,8212,2552,5062,6892,9143,7244,1291,5441,452

Abbott Laboratories Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
Research & Development 1,0101,152364371351460346363357386
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide